laxabon
farmagon - makrogol 3350 / natriumsulfat / natriumhydrogenkarbonat / natriumklorid / kaliumklorid - pulver til mikstur, oppløsning - 59 g / 5.69 g / 1.71 g / 1.44 g / 0.75 g
plenvu
norgine b.v. - makrogol 3350 / natriumaskorbat / natriumsulfat, vannfritt / askorbinsyre / natriumklorid / kaliumklorid - pulver til mikstur, oppløsning - 140 g / 48.11 g / 9 g / 7.54 g / 5.2 g / 2.2 g
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
xyrem
ucb pharma ltd - natriumoksybat - cataplexy; narcolepsy - andre nervesystemet narkotika - behandling av narkolepsi med katapleksi hos voksne pasienter.
promixin 1 mill ie
zambon spa - kolistimetatnatrium - pulver til infusjonsvæske, oppløsning - 1 mill ie
isoprenaline hydrochloride macure 0.2 mg/ ml
macure pharma aps - isoprenalinhydroklorid - konsentrat til infusjonsvæske, oppløsning - 0.2 mg/ ml
salidex 2.92 g/ l / 35 g/ l
b. braun melsungen ag - natriumklorid / glukose - infusjonsvæske, oppløsning - 2.92 g/ l / 35 g/ l
fenylefrin unimedic 0.05 mg/ ml
unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.05 mg/ ml
fenylefrin unimedic 0.1 mg/ ml
unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.1 mg/ ml
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.